Guide to the environmental risk management authorities under the Food and Drugs Act: Key considerations for managing risks to the environment

This annex sets out the considerations that factor into selecting the most appropriate approach for managing risks to the environment from therapeutic products under the Food and Drugs Act (FDA).

Which authorities under the FDA will be used to manage a risk to the environment will depend on an analysis of environmental, health, economic and social considerations at the time the decision is made. Each consideration may have a different influence or “weight” in determining which risk management authority is most appropriate to address a risk to the environment. If the situation changes or significant new information becomes available after selecting the approach to risk management, then the approach can be updated accordingly.

The following is a non-exhaustive list of elements that the Minister may consider when selecting an approach to environmental risk management for a therapeutic product:

Page details

Date modified: